3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
17
Lung Neoplasms
5
Ovarian Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Esophageal Neoplasms
3
Stomach Neoplasms
2
Retinoblastoma
2
Neoplasms
2
Uterine Cervical Neoplasms
1
Squamous-Cell Lung Cancer
1
Retinal Neoplasms
1
Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
1
Resectable Non-small Cell Lung Cancer
1
Resectable Lung Non-Small Cell Carcinoma
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Cancer Recurrent
1
Oropharyngeal Neoplasms
1
NSCLC
1
Lymphatic Metastasis
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Bronchogenic
1
Carcinoma
1
Interventions
toripalimab
1
sintilimab
1
pemigatinib
1
Vinorelbine
1
Platinum Compounds
1
Nivolumab
1
Ipilimumab
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Advanced Non Small Cell Lung Cancer
×
Platinum Compounds
×
Clear all
NCT04144608
2024-08-09
TOGATHER
Hunan Province Tumor Hospital
Phase 2
Completed
40 enrolled